Tags: drug costs

12/12/2017

Gene therapy and hemophilia: Washington Post wisely tells readers ‘the study has some limitations’

1 10/21/2016

Are expensive, potent anti-inflammatory drugs a future option for depression? CNN’s story needed more scrutiny of evidence

3/6/2016

False balance in CNN coverage of female sexual dysfunction: anecdotes given equal weight as systematic evidence review

2/26/2016

Interesting but evidence-free story on ibuprofen skin patch

1/7/2016

A gloss over costs in coverage of competing blood pressure meds — but also some strengths

1 11/13/2015

WSJ whiffs on meaningful aspects of new melanoma drug approval — including $17,600/month price tag

2 10/29/2015

Thorough look at underuse of long-term reversible contraceptives

1 9/28/2015

With just 226 words, NYT can’t deliver needed context on Alzheimer’s agitation study

4/22/2015

Story on new melanoma drug combo neglects to mention $250,000 price tag

Story Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

HealthNewsReview.org @healthnewsrevu ·

The tale of two “negative” studies. Or, how spin is applied to make research findings look more impressive. A must read. https://johnmandrola.substack.com/p/the-tale-of-two-negative-studies

Reply on Twitter 1541491162799800323 Retweet on Twitter 1541491162799800323 1 Like on Twitter 1541491162799800323 2 Twitter 1541491162799800323

Retweet on Twitter HealthNewsReview.org Retweeted

Carolyn Thomas ☮️ @heartsisters ·

The @nytimes chose to interview one of the editors of the @AnnalsofIM (publisher of this paper) who "gushed with extraordinary glee: It’s huge! There are very few things that reduce your mortality by 30%."
Turns out coffee is not one of those few things despite all that glee. https://twitter.com/garyschwitzer/status/1533202075928215558

Reply on Twitter 1539728971138338816 Retweet on Twitter 1539728971138338816 1 Like on Twitter 1539728971138338816 5 Twitter 1539728971138338816